Arcus Biosciences, Inc.

RCUS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $1.35B

Liabilities Breakdown FY2022

Total Liabilities: $688.0M